Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

784 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies.
Bar-Or A, Pender MP, Khanna R, Steinman L, Hartung HP, Maniar T, Croze E, Aftab BT, Giovannoni G, Joshi MA. Bar-Or A, et al. Among authors: giovannoni g. Trends Mol Med. 2020 Mar;26(3):296-310. doi: 10.1016/j.molmed.2019.11.003. Epub 2019 Dec 17. Trends Mol Med. 2020. PMID: 31862243 Free PMC article. Review.
Emerging therapies in multiple sclerosis.
Farrell R, Heaney D, Giovannoni G. Farrell R, et al. Among authors: giovannoni g. Expert Opin Emerg Drugs. 2005 Nov;10(4):797-816. doi: 10.1517/14728214.10.4.797. Expert Opin Emerg Drugs. 2005. PMID: 16262563 Review.
Infectious causes of multiple sclerosis.
Giovannoni G, Cutter GR, Lunemann J, Martin R, Münz C, Sriram S, Steiner I, Hammerschlag MR, Gaydos CA. Giovannoni G, et al. Lancet Neurol. 2006 Oct;5(10):887-94. doi: 10.1016/S1474-4422(06)70577-4. Lancet Neurol. 2006. PMID: 16987736 Review. No abstract available.
Multiple sclerosis: the environment and causation.
Giovannoni G, Ebers G. Giovannoni G, et al. Curr Opin Neurol. 2007 Jun;20(3):261-8. doi: 10.1097/WCO.0b013e32815610c2. Curr Opin Neurol. 2007. PMID: 17495618 Review.
Epstein-Barr virus and multiple sclerosis.
Salvetti M, Giovannoni G, Aloisi F. Salvetti M, et al. Among authors: giovannoni g. Curr Opin Neurol. 2009 Jun;22(3):201-6. doi: 10.1097/WCO.0b013e32832b4c8d. Curr Opin Neurol. 2009. PMID: 19359987 Review.
Cerebrospinal fluid biomarkers in multiple sclerosis.
Tumani H, Hartung HP, Hemmer B, Teunissen C, Deisenhammer F, Giovannoni G, Zettl UK; BioMS Study Group. Tumani H, et al. Among authors: giovannoni g. Neurobiol Dis. 2009 Aug;35(2):117-27. doi: 10.1016/j.nbd.2009.04.010. Epub 2009 May 5. Neurobiol Dis. 2009. PMID: 19426803 Review.
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis.
Polman CH, Bertolotto A, Deisenhammer F, Giovannoni G, Hartung HP, Hemmer B, Killestein J, McFarland HF, Oger J, Pachner AR, Petkau J, Reder AT, Reingold SC, Schellekens H, Sørensen PS. Polman CH, et al. Among authors: giovannoni g. Lancet Neurol. 2010 Jul;9(7):740-50. doi: 10.1016/S1474-4422(10)70103-4. Lancet Neurol. 2010. PMID: 20610349
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis.
Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, Wolinsky JS, Ziemssen T. Berger JR, et al. Among authors: giovannoni g. Ann Neurol. 2010 Sep;68(3):409-11. doi: 10.1002/ana.22083. Ann Neurol. 2010. PMID: 20818795 No abstract available.
784 results